Intravenous and Subcutaneous Immunoglobulin Therapy

Intravenous Immunoglobulin Therapy (IVIG) is used to help treat immune system disorders. It is infused intermittently every 3-8 weeks depending on the disease state and response to therapy.
  • IV access required
  • Administered utilizing an infusion pump
  • Home health nurse will visit patient to ensure IV access as well as monitor patient throughout the infusion. RN will adjust the rate based on patient response to infusion.
  • No first dosing at home



Indications/Candidates for Intravenous Immunoglobulin Therapy
  • CVID (Common Variable Immunodeficiency)
  • Chronic Inflammatory demyelinating polyneuropathy (CIDP)
  • Primary immunodeficiency disorders

Subcutaneous Immunoglobulin Therapy (ScIG) is an Immunoglobulin that is administered under the skin. It is administered intermittently every 1-4 weeks depending on the medication and MD orders.
  • No IV access required
  • Multiple access sites may be required
  • Administered using an infusion pump
  • Home Health nurse is required for initial teaching, after which patient can self-infuse.
  • Local site reactions can be expected.
  • No first dosing at home if Nieve to IG therapy.



Indications/Candidates for Subcutaneous Immunoglobulin Therapy (ScIG)
  • Primary humoral immunodeficiency (PI) in adults
  • Hizentra and Gammagard can be utilized in patients 2 years of age or older.